Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study
Pappo, A. S., Patel, S., Crowley, J., Reinke, D. K., Staddon, A. P., Kuenkele, K., Chawla, S. P., Benjamin, R. S., Helman, L. J., Baker, L. H.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article